Case Report: Persistent fifth aortic arch with coarctation and fourth aortic arch interruption causing infant heart failure – the prenatal and postnatal echocardiographic course - Top-Institutions - MDSpire

Case Report: Persistent fifth aortic arch with coarctation and fourth aortic arch interruption causing infant heart failure – the prenatal and postnatal echocardiographic course

  • By

  • Xiaohong Zhang

  • Guozhen Yuan

  • Kunpeng Li

  • Yangcan Duan

  • Junli Hu

  • Dongchen Fan

  • May 22, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Cardiology
    • Fetal Cardiology
    • Congenital Heart Surgery

  • #2

    Texas Children’s Hospital
    Texas Children’s Hospital

    Houston, Texas

    Key Differentiators

    • Pediatric Cardiology
    • Fetal Cardiology
    • Congenital Heart Surgery

  • #3

    UCSF neonatal intensive care unit
    UCSF neonatal intensive care unit

    San Francisco, California

    Key Differentiators

    • Neonatology
    • Pediatric Cardiology

  • #4

    Evelina London Children’s Hospital
    Evelina London Children’s Hospital

    London, England

    Key Differentiators

    • Pediatric Cardiology
    • Neonatology

  • #5

    King’s College Hospital
    King’s College Hospital

    London, England

    Key Differentiators

    • Pediatric Cardiology
    • Neonatology

Original Source(s)

Case Report: Persistent fifth aortic arch with coarctation and fourth aortic arch interruption causing infant heart failure – the prenatal and postnatal echocardiographic course

  • by Xiaohong Zhang, Guozhen Yuan, Kunpeng Li, Yangcan Duan, Junli Hu, Dongchen Fan

  • May 22, 2026

Related Content

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.